During the COVID-19 outbreak, the flaws in U.S. healthcare supply chains became apparent, especially concerning the availability of essential medicines. They highlighted the need for proactive and data-driven strategies to improve supply chain resilience. A lack of predictive systems, real-time inventory management, and supply chain transparency during the pandemic contributed to stockouts, increased costs, and compromised patient care in the absence of robust predictive systems, real-time inventory management, and supply chain transparency. This crisis offers lessons about the central importance of carrying out the strategies presented in this study. Technologies such as artificial intelligence, blockchain, and real-time inventory systems can revolutionize the healthcare supply chain and help stakeholders predict and mitigate disruptions before they become big. For instance, AI can help with demand forecasting while blockchain helps to prevent counterfeit medicines by enforcing transparency and traceability. However, these technologies only work as well as the systems and policies that support their use. To achieve resilience, policymakers must set clear regulatory frameworks that enable integration of new technologies to ensure patient security and data protection, support public-private partnerships to pilot new solutions and scale successful models nationally, fund modernization of legacy systems, strengthen data infrastructure, and invest in workforce development to close skills gaps. A future crisis can be prevented only when technology is aligned with policy through the collaborative efforts of all the stakeholders. The U.S. healthcare system can learn from the challenges of the pandemic and prioritize the application of data-driven strategies to move away from reactive crisis management to proactive resilience. Its not just a healthcare imperative – its a key element of national security and public health.